SwanBio Therapeutics: Funding, Investors & Team (Oct 2026)
SwanBio Therapeutics develops a therapeutic technology that aims to significantly improve the clinical effectiveness in treating neurological diseases. They specifically focus on creating and marketing genetically based treatments for various neurological disorders.
SwanBio Therapeutics has raised $118M across 3 funding rounds on record, the most recent an undisclosed round of $10.0M announced in Oct 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SwanBio Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2023.
SwanBio Therapeutics Funding Rounds
SwanBio Therapeutics raised $52.0M in an undisclosed round announced in Apr 2020.
2.1 years later, a Series B of $56.0M was announced in May 2022.
1.4 years later, an undisclosed round of $10.0M was announced in Oct 2023.
SwanBio Therapeutics Founders and Leadership Team
Contact details for the SwanBio Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →SwanBio Therapeutics Funding Compared to Other Biotechnology Startups
SwanBio Therapeutics' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SwanBio Therapeutics in Biotechnology and Bala Cynwyd
Companies Similar to SwanBio Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
SwanBio Therapeutics Funding FAQs
What does SwanBio Therapeutics do?
SwanBio Therapeutics develops a therapeutic technology that aims to significantly improve the clinical effectiveness in treating neurological diseases. They specifically focus on creating and marketing genetically based treatments for various neurological disorders.
How much funding has SwanBio Therapeutics raised?
SwanBio Therapeutics has raised $118M across 3 rounds on record. The most recent is an undisclosed round of $10.0M announced in Oct 2023.
When did SwanBio Therapeutics last raise funding?
SwanBio Therapeutics' most recent funding round on record is an undisclosed round of $10.0M, announced in Oct 2023.
Who founded SwanBio Therapeutics?
FundedIQ lists Karen Kozarsky (Founder) at SwanBio Therapeutics.
Who is the CEO of SwanBio Therapeutics?
Tom Anderson is listed as CEO at SwanBio Therapeutics.
Where is SwanBio Therapeutics headquartered?
SwanBio Therapeutics is based in Bala Cynwyd, Pennsylvania, United States.
How many employees does SwanBio Therapeutics have?
SwanBio Therapeutics is in the 11-50 employee band.
How does SwanBio Therapeutics' funding compare to other Biotechnology startups?
SwanBio Therapeutics' latest round of $10.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's SwanBio Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SwanBio Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.